Medical specialists from Brazil tagged as investigators in clinical trials studying Blood Coagulation Disorders, Inherited

Total 1 results

Rosana S Dantas, PhD
Seen in:
- São Paulo, Ribeirão Preto, Hospital Estadual de Ribeirão Preto
Trials:
- NCT01339611 (Principal Investigator)
Conditions:

Clinical Trials on Blood Coagulation Disorders, Inherited

McMaster University
Epitome Pharmaceuticals

Terminated

Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

Hypoprothrombinemia

Canada
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Epidemiology and Immunology of Hemophilia A Inhibitors

Hemophilia A | Blood Disease
Enzyre B.V.
Indiana Hemophilia & Thrombosis Center

Not yet recruiting

Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia A Monitoring

Hemophilia A

United States
Hospices Civils de Lyon

Recruiting

EVALUATION OF THE OVERALL HAEMOSTATIC CAPACITY OF MIM8 WITH GLOBAL HAEMOSTASIS ASSAYS AND FIBRIN CLOT ULTRASTRUCTURE (Mim8-TGT)

Hemophilia A

France
Biocad

Recruiting

A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A (EDELWEISS)

Hemophilia A

Russian Federation
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Hemophilia A

Spain, Canada, United States, New Zealand, Italy, Poland
University Hospital, Grenoble

Recruiting

Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer (EMISTAT)

Hemophilia A

France
Centre Hospitalier Universitaire de Saint Etienne

Recruiting

In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients

Hemophilia

France
World Federation of Hemophilia

Not yet recruiting

The World Federation of Hemophilia Gene Therapy Registry (WFH GTR)

Hemophilia
Prof. Dr. Dr. Thomas Hilberg

Recruiting

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis (CLHEAR)

Hemophilia A

Germany

Subscribe